Venture
Bright Peak Therapeutics, Inc.
Latest Form D 2024-06-11- CIK 1813343
- State CA
- Other
- 2 Form D offerings since 2021-06-11
- Total sold
- $197M
- across 2 offerings
- Rounds
- 2
- Form D offerings since 2021-06-11
- Latest round
- $90M
- 2024-06-11 · 021-515688
- Investors
- 21
- on the latest round
Connected
named in its Form D filingsOfferings · since 2021-06-112 Form D offeringsExemptions506(b)People · Item 3Fredrik Wiklund + 11 moreInvestors · dashboard4 inferred investors
Bright Peak Therapeutics, Inc.CIK 1813343
Round timeline
amount sold · by first filed2024-06-11 · $90M
- 2021-06-11$107M021-402693
- 2024-06-11$90M021-515688
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($107M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-515688 | First filed2024-06-11 | Latest2024-06-11 | Sought$90M | Sold$90M | Investors21 | Exemptions506(b) |
| 021-402693 | First filed2021-06-11 | Latest2021-06-11 | Sought$107M | Sold$107M | Investors17 | Exemptions506(b) |
Who backs Bright Peak Therapeutics, Inc. — 4 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-06-11
| Name | Relationship |
|---|---|
| Fredrik Wiklund | RelationshipExecutive Officer, Director |
| Bertolt Kreft | RelationshipExecutive Officer |
| Vijaya Pattabiraman | RelationshipExecutive Officer |
| Matthew Robbins | RelationshipExecutive Officer |
| Jon Wigginton | RelationshipExecutive Officer |
| Asish Xavier | RelationshipDirector |
| Emily Minkow | RelationshipDirector |
| Tom Woiwode | RelationshipDirector |
| Jacob Chacko | RelationshipDirector |
| Leena Gandhi | RelationshipDirector |
| Laura Shawver | RelationshipDirector |
| Christine Siu | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Other
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2021-06-11
- Latest filing
- 2024-06-11
Who backs Bright Peak Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗